Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants [Phase 2]

View source ↗

Summary

Phase 2 study to evaluate the efficacy, safety, and pharmacokinetics of obinutuzumab in adolescents with active Class III/IV lupus nephritis, with additional sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• Obinutuzumab (obinutuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lupus Nephritis | Phase 2 | Status: RECRUITING